Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Gitlab Inc’s current trading price is -23.02% away from its 52-week high, while its distance from the 52-week low is
Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Neo Concept International Group Holdings Ltd’s current trading price is -95.04% away from its 52-week high, while its distance from the 52-week
The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. This year’s metric has recorded a Price decrease of -21.64%. However, over the past six months, we’ve seen a
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The metric has seen a significant gain of 41.26% since the start of this calendar year. Looking back over
Marinus Pharmaceuticals Inc’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $11.26 on 01/08/24, with the lowest value being $0.22 on 12/23/24. 52-week price history of MRNS Stock A stock’s 52-week high and low prices can
Amphenol Corp saw a rather consistency, in terms of market performance. The company’s stock reached its highest point at $75.78 on 12/16/24, while the lowest price for the same duration was marked at $46.94 on 01/04/24. 52-week price history of APH Stock Studying a stock’s
Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Oncolytics Biotech, Inc’s current trading price is -36.60% away from its 52-week high, while its distance from the 52-week low is 36.60%.
A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Karyopharm Therapeutics Inc’s current trading price is -69.49% away from its 52-week high, while its distance from the 52-week low is -1.10%. The stock’s
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. This year’s metric has recorded a Price increase of 238.70%. However, over the past six months, we’ve seen a
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. The metric has seen a significant loss of -63.43% since the start of this calendar
All rights reserved © 2024, Powered By Smart TechOne
